UnitedHealth Keeps Raising Guidance. Here's What a $10,000 Investment Could Be Worth if the Turnaround Sticks.

Source The Motley Fool

Key Points

  • UnitedHealth recently raised its 2026 adjusted earnings guidance for the third time this year, to at least $20.50 per share.

  • Raising premiums, cutting certain benefits, and exiting less profitable markets lifted UnitedHealth’s health insurance operating margin to 3.3%.

  • Optum has restructured operations and exited less attractive contracts, while automation and AI could streamline administration in its technology business.

  • Motley Fool Issues Rare "Total Conviction" Buy Alert ›

UnitedHealth Group (NYSE: UNH) may finally be turning a corner after a difficult stretch. These days, with management repeatedly raising earnings guidance (most recently on Oct. 13) and profitability showing signs of recovery, could the healthcare giant be poised for a comeback?

Here's what a $10,000 investment could become if the turnaround holds.

Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »

A stethoscope and red plastic toy heart on top of a financial chart.

Image source: Getty Images.

UnitedHealth is finally putting its turnaround into action

For much of the past two years, UnitedHealth has struggled to convince investors it could turn its business around. But that picture is starting to change. In fact, UnitedHealth has now raised its full-year earnings guidance three times in 2026.

Its latest third-quarter results offered another encouraging sign that management's efforts are starting to pay off. Specifically, the company reported adjusted earnings of $4.69 per share, compared with $2.92 in the same quarter last year. But more importantly, management raised its full-year 2026 adjusted earnings outlook to at least $20.50 per share, up from its previous range of between $19.50 and $20.00.

Still, for investors, the bigger question now is whether these improvements represent a temporary rebound or the beginning of a more sustainable recovery. So far, the latest results have given more reasons to be optimistic.

Medicare Advantage is becoming a strong earnings driver

One of UnitedHealth's biggest challenges has been rising medical costs across its insurance business, particularly in Medicare Advantage. In response, the company had to begin making big changes to the business. These included raising premiums, reducing certain benefits, and exiting less profitable markets.

The strategy meant sacrificing short-term membership growth, but the results suggest that this new approach is working. In fact, in the third quarter, the health insurance segment generated $2.8 billion in operating earnings, compared with $1.8 billion a year earlier. Plus, its operating margin improved to 3.3% from 2.1%.

Looking ahead, management sees opportunities to further improve its Medicare Advantage business in 2027. Specifically, the company is focusing on markets and products where it believes it can achieve more durable margins, including special needs plans for seniors with more complex healthcare needs.

Meanwhile, UnitedHealth's healthcare services business is turning into a strong growth driver.

Optum could become another major growth catalyst

Perhaps one of UnitedHealth's most important competitive advantages comes from Optum, which operates across healthcare delivery, pharmacy services, and technology segments. This diversification is valuable as the healthcare industry looks for ways to trim costs, improve efficiency, and coordinate healthcare.

There is an additional long-term opportunity in Optum's technology operations. For example, automation and artificial intelligence (AI) could help streamline administrative processes and improve the way patients and providers interact with the healthcare system.

All told, if existing operations continue to recover and productivity improvements from automation and AI materialize, UnitedHealth would be better positioned to deliver stronger earnings growth. That raises the question of what stronger earnings growth could mean for investors.

The turnaround could reward patient investors

Ultimately, if the company executes its turnaround plans well, investors could be rewarded. To illustrate, starting with its 2026 adjusted earnings per share (EPS) projection of at least $20.50 and applying the low end of management's long-term earnings growth target of 13%-16%, adjusted EPS could reach around $23.17 in 2027.

From there, applying a 22 price-to-earnings (P/E) ratio produces a price target of around $510 per share, which would turn a $10,000 investment into about $12,400.

In the table below, I used a base case assuming 14.5% growth and a slightly higher 23 P/E, and a bull case using the upper end of growth and a 24 multiple.

Scenario 2027 EPS growth 2027 adjusted EPS P/E multiple Target price Upside vs. $412.02 last close $10,000 could become
Conservative 13% $23.17 22 $510 24% $12,400
Base 14.5% $23.47 23 $540 31% $13,100
Bull 16% $23.78 24 $571 39% $13,900

Data source: Calculations by the author.

Overall, if management can sustain the turnaround and restore profitability across the company, investors could be looking at a much stronger investment case in the years ahead.

Should you buy stock in UnitedHealth Group right now?

Before you buy stock in UnitedHealth Group, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and UnitedHealth Group wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $327,620!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $959,410!*

Now, it’s worth noting Stock Advisor’s total average return is 802% — a market-crushing outperformance compared to 205% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of November 17, 2026.

Rick Orford has no position in any of the stocks mentioned. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Gold hit a one-year low while central banks bought 321 tonnes — the sellers were never the ones you thinkSpot gold closed at 3,876 on Thursday, down 2.8% and its lowest close in more than a year, with an intraday low near 3,852. The dollar is at a 19-month high of 103.21 and the 10-year yield is at 5.10%, so the price move is easy to explain. What is harder to explain is who sold: central banks bought 321 tonnes in Q3, the PBoC added for a 24th straight month, ETF holdings are near a record 4,256 tonnes, and roughly 95% of the futures selling came from non-reportable and sovereign-type accounts rather than hedge funds. This piece separates the two books that have to balance.
Author  Irene Q.
Nov 13, Fri
Spot gold closed at 3,876 on Thursday, down 2.8% and its lowest close in more than a year, with an intraday low near 3,852. The dollar is at a 19-month high of 103.21 and the 10-year yield is at 5.10%, so the price move is easy to explain. What is harder to explain is who sold: central banks bought 321 tonnes in Q3, the PBoC added for a 24th straight month, ETF holdings are near a record 4,256 tonnes, and roughly 95% of the futures selling came from non-reportable and sovereign-type accounts rather than hedge funds. This piece separates the two books that have to balance.
placeholder
Anthropic is six times oversubscribed at $1.4 trillion while Nvidia is down 32% — the AI trade has two pricesAnthropic lists on Nasdaq as ANT on Thursday at $70 ~ $78 a share, raising up to $64.4 billion at a target valuation near $1.4 trillion, and the book is reportedly six times covered. In the same six weeks, Nvidia has fallen 32% and the QQQ is 10.9% below its October peak. Private capital and public markets are marking the same AI complex at two very different prices. This piece separates the two books: what the S-1 shows, who is anchoring the $26 billion private placement, and what Thursday's debut would have to do to change the public tape.
Author  Irene Q.
Nov 16, Mon
Anthropic lists on Nasdaq as ANT on Thursday at $70 ~ $78 a share, raising up to $64.4 billion at a target valuation near $1.4 trillion, and the book is reportedly six times covered. In the same six weeks, Nvidia has fallen 32% and the QQQ is 10.9% below its October peak. Private capital and public markets are marking the same AI complex at two very different prices. This piece separates the two books: what the S-1 shows, who is anchoring the $26 billion private placement, and what Thursday's debut would have to do to change the public tape.
placeholder
Gold Price Analysis Today | Forex Gold Analysis | XAU/USD Analysis - November 16, 2026Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for November 16, 2026. Read on for the details.
Author  Mitrade
Nov 16, Mon
Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for November 16, 2026. Read on for the details.
placeholder
Weekly Report: DXY 103.41, 10-year 5.15%, AUD carry 3bp — three FX regimes flipped in one weekThe dollar index rose 1.09% to 103.41, a 19-month high, while the US 10-year closed at 5.154% and the Australia-US two-year spread collapsed to about 3 basis points from 36. EURUSD fell 1.59% to 1.1024, USDJPY rose 1.51% to 159.78 and AUDUSD fell 1.79% to 0.6764, a 10-month low. Three FX regimes — the broad dollar, the US rate level and the Australian carry premium — flipped in the same week. This report marks the thresholds, ranks which one can flip back first, and lists the week's calendar.
Author  Irene Q.
Nov 16, Mon
The dollar index rose 1.09% to 103.41, a 19-month high, while the US 10-year closed at 5.154% and the Australia-US two-year spread collapsed to about 3 basis points from 36. EURUSD fell 1.59% to 1.1024, USDJPY rose 1.51% to 159.78 and AUDUSD fell 1.79% to 0.6764, a 10-month low. Three FX regimes — the broad dollar, the US rate level and the Australian carry premium — flipped in the same week. This report marks the thresholds, ranks which one can flip back first, and lists the week's calendar.
placeholder
Gold Price Analysis Today | Forex Gold Analysis | XAU/USD Analysis - November 17, 2026Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for November 17, 2026. Read on for the details.
Author  Mitrade
21 hours ago
Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for November 17, 2026. Read on for the details.
goTop
quote